Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Monserrat Llaguno‐Munive"'
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 19, p 10712 (2024)
Within the field of nanomedicine, which is revolutionizing cancer treatment, solid lipid nanoparticles (SLNs) have shown advantages over conventional chemotherapy when tested on cancer cells in preclinical studies. SLNs have proven to be an innovativ
Externí odkaz:
https://doaj.org/article/8d551c5e63ab4cf6a469b737401b09d8
Autor:
Lucía Pérez‐Sánchez, Misael A. Ortiz de la O, Marco A. Álvarez‐Pérez, Monserrat Llaguno‐Munive, Osmar A. Chanes‐Cuevas, Janeth Serrano‐Bello
Publikováno v:
MedComm – Biomaterials and Applications, Vol 3, Iss 1, Pp n/a-n/a (2024)
Abstract The challenge of three‐dimensional (3D) printing by polymeric extrusion in tissue bioengineering is to control with precision the microarchitecture and porous interconnectivity of scaffolds, as well as search for models that allow and faci
Externí odkaz:
https://doaj.org/article/7076aef035084458a1294334da9036b8
Autor:
Monserrat Llaguno-Munive, Wilberto Villalba-Abascal, Alejandro Avilés-Salas, Patricia Garcia-Lopez
Publikováno v:
Journal of Imaging, Vol 9, Iss 10, p 212 (2023)
Cancer is a public health problem requiring ongoing research to improve current treatments and discover novel therapies. More accurate imaging would facilitate such research. Near-infrared fluorescence has been developed as a non-invasive imaging tec
Externí odkaz:
https://doaj.org/article/b551c47468e6429c8f2a28638b2282e1
Autor:
Karen Ocaña-Arakachi, Julio Martínez-Herculano, Rafael Jurado, Monserrat Llaguno-Munive, Patricia Garcia-Lopez
Publikováno v:
Pharmaceuticals, Vol 16, Iss 10, p 1337 (2023)
Although cisplatin is an effective chemotherapy drug used against many types of cancer, it has poor bioavailability, produces severe adverse effects, and frequently leads to tumor resistance. Consequently, more effective formulations are needed. The
Externí odkaz:
https://doaj.org/article/c708f14421c94b4ca651d32cfc476734
Autor:
Carlos D. Cruz-Hernández, Marian Cruz-Burgos, Sergio A. Cortés-Ramírez, Alberto Losada-García, Ignacio Camacho-Arroyo, Patricia García-López, Elizabeth Langley, Vanessa González-Covarrubias, Monserrat Llaguno-Munive, Martha E. Albino-Sánchez, José L. Cruz-Colín, Carlos Pérez-Plasencia, Fredy O. Beltrán-Anaya, Mauricio Rodríguez-Dorantes
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background Prostate cancer (PCa) is the second cause of cancer related death in North American men. Androgens play an important role in its progression by regulating the expression of several genes including fusion ones that results from str
Externí odkaz:
https://doaj.org/article/f04cd89727b9453c9cb8d7ea23d883a5
Publikováno v:
Pharmaceutics, Vol 14, Iss 11, p 2443 (2022)
Cancer represents a very grave and quickly growing public health problem worldwide. Despite the breakthroughs in treatment and early detection of the disease, an increase is projected in the incidence rate and mortality during the next 30 years. Thus
Externí odkaz:
https://doaj.org/article/bb3bfe6e77b04930baa4e042a32870d3
Autor:
Omar Prado-Carrillo, Abner Arenas-Ramírez, Monserrat Llaguno-Munive, Rafael Jurado, Jazmin Pérez-Rojas, Eduardo Cervera-Ceballos, Patricia Garcia-Lopez
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 14, p 7715 (2022)
Chronic myeloid leukemia (CML) is a hematologic disorder characterized by the oncogene BCR-ABL1, which encodes an oncoprotein with tyrosine kinase activity. Imatinib, a BCR-ABL1 tyrosine kinase inhibitor, performs exceptionally well with minimal toxi
Externí odkaz:
https://doaj.org/article/8b9438f5b35342c98d1ed0688290d3df
Autor:
Monserrat Llaguno-Munive, Sebastián León-Zetina, Inés Vazquez-Lopez, María del Pilar Ramos-Godinez, Luis A. Medina, Patricia Garcia-Lopez
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Externí odkaz:
https://doaj.org/article/c065f9a9d9ba4c8496fec0177834fa07
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Glioma is the most common and aggressive primary tumor of the central nervous system. The standard treatment for malignant gliomas is surgery followed by chemoradiotherapy. Unfortunately, this treatment has not produced an adequate patient response,
Externí odkaz:
https://doaj.org/article/120aa54d52bb4239a5f75370c30a174b
Autor:
Monserrat Llaguno-Munive, Sebastián León-Zetina, Inés Vazquez-Lopez, María del Pilar Ramos-Godinez, Luis A. Medina, Patricia Garcia-Lopez
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Glioblastoma, the most common primary central nervous system tumor, is characterized by extensive vascular neoformation and an area of necrosis generated by rapid proliferation. The standard treatment for this type of tumor is surgery followed by che
Externí odkaz:
https://doaj.org/article/5f9fbb0995ba4b4e82fa6fce7ba82e39